Pluton Biosciences

Unearthing world-changing solutions.


Raised to Date: Raised: $98,000

Total Commitments ($USD)



Start Date


Close Date


Min. Goal
Max. Goal
Min. Investment


Security Type


SEC Filing Type

RegCF    Open SEC Filing

Rolling Commitments ($USD)

Reporting Date


Days Remaining
% of Min. Goal
% of Max. Goal
Likelihood of Max
Avg. Daily Raise


Create a free account today to gain access to KingsCrowd analytics.
Year Founded



Healthcare & Pharmaceuticals

Tech Sector


Pluton Biosciences is raising funds on Nvsted. The company is using its innovative process to realize the potential of undiscovered microbes. The Microgaming Innovation Engine of Pluton Biosciences makes the discovery of novel microbes possible and commercially viable. Pluton Biosciences is discovering the next-generation products for carbon sequestration, agriculture, biomaterials, and bioremediation. Charlie Walch and Barry Goldman founded Pluton Biosciences in January 2017. The current crowdfunding campaign has a minimum target of $75,000 and a maximum target of $150,000. The campaign proceeds will be used for marketing, equipment purchases, future wages, repayment of debt, and general working capital.

Summary Profit and Loss Statement

FY 2018 FY 2017












Net Income



Summary Balance Sheet

FY 2018 FY 2017




Accounts Receivable



Total Assets



Short-Term Debt



Long-Term Debt



Total Liabilities



Financials as of: 01/04/2019
Create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
Pluton Biosciences 09/30/2021 Self Managed - $6,682,968 Equity - Common Funded RegD 506(b)
Pluton Biosciences 06/07/2019 Nvsted - $98,000 Debt Funded RegCF
Pluton Biosciences 01/02/2019 Self Managed - $0 Debt Funded RegD 506(c)
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)


$12.42 /month
billed annually
Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings (excluding risk)
Advanced company search ( with ratings)
Markets page filters and historical industry data
Get Edge Annual

Edge Pro

$41.58 /month
billed annually
Full site access including KingsCrowd's qualitative analyst reports.
Plan Includes:
Everything in Edge, plus
Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
Search and filter based on Analyst Reports
In-depth risk ratings for every raise
Get Edge Pro Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.

Create your first portfolio

Create your own startup investment portfolio on KingsCrowd.

Track all of your startup investments in one place using our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Pluton Biosciences on Nvsted 2019
Platform: Nvsted
Security Type: Debt

Follow company

Follow Pluton Biosciences on Nvsted 2019

Buy Pluton Biosciences's Deal Report

Warning: according to the close date for this deal, Pluton Biosciences may no longer be accepting investments.

Pluton Biosciences Deal Report

Get KingsCrowd’s comprehensive report on Pluton Biosciences including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Pluton Biosciences is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Pluton Biosciences deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge Pro